-transparent.png){kind=logo}
In previous studies we have shown that AKR mice could be protected from spontaneous leukemia by specific immunotherapy in combination with splenectomy. In this experiment we investigated the effects of nonspecific immunotherapy with C. parvum in a similar regimen. It was found that bi-weekly, ip inoculations of 0.7 mg of C. parvum could significantly protect AKR mice from spontaneous tumors, and that splenectomy could not modify this effect. Thus, the spleen does not appear to play a determinant role in mediating the protective effects of C. parvum, as had been suggested in other systems.
Related Publications
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
May 1978,
Proceedings of the Royal Society of London. Series B, Biological sciences,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
August 1986,
The Journal of surgical research,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
January 1991,
Immunopharmacology and immunotoxicology,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
October 1977,
Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
May 1977,
Journal of the National Cancer Institute,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
November 1966,
Nature,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
November 1976,
Cancer research,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
December 1976,
Transplantation proceedings,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
December 1972,
Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
J H Check, and
G A Silverman, and
R L Dryden, and
L W Brady
January 1980,
Cancer,
